Asset Details
Do you wish to reserve the book?
The relationship between acrolein and oxidative stress in COPD: in systemic plasma and in local lung tissue
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The relationship between acrolein and oxidative stress in COPD: in systemic plasma and in local lung tissue
Do you wish to request the book?
The relationship between acrolein and oxidative stress in COPD: in systemic plasma and in local lung tissue
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The relationship between acrolein and oxidative stress in COPD: in systemic plasma and in local lung tissue
2019
Overview
Cigarette smoke produces a high level of acrolein, which is thought to be pathogenically involved in the development of chronic obstructive pulmonary disease (COPD). The present study investigated the pathological role of acrolein in the development of COPD.
Acrolein concentration was measured in plasmas obtained from 47 patients with COPD and 18 current smokers without COPD, and in supernatants of homogenized lung tissues obtained from 10 never-smokers, 8 current smokers, and 8 patients with COPD by high-performance liquid chromatography. Oxidant status and antioxidant activity were measured using derivatives of reactive oxygen metabolite (d-ROM) and bio-antioxidant power (BAP), respectively, in the Free Radical Elective Evaluation FRAS4 system. In addition, immunohistochemistry was used to evaluate the over-presentation of acrolein in lung tissues of patients with COPD.
Plasma concentrations of acrolein were significantly higher in the patients with COPD than the non-COPD smokers (
<0.001), which significantly correlated with the oxidant status in patients with COPD (R=0.69,
<0.05). Similar pathological alterations in acrolein concentrations were found in the lung tissue supernatants of patients with COPD, which significantly correlated with the oxidant status in patients with COPD. Furthermore, acrolein was strongly expressed in the lung tissues of patients with COPD.
The increased acrolein concentrations were highly involved in the pathogenesis of COPD through interference in the balance of oxidative stress versus antioxidant potentiality.
Publisher
Dove Medical Press Limited,Dove Medical Press Ltd,Dove Press,Dove,Dove Medical Press
Subject
/ Aged
/ Chronic obstructive lung disease
/ Chronic obstructive pulmonary disease
/ Female
/ High performance liquid chromatography
/ Humans
/ Male
/ Plasma
/ Proteins
/ Pulmonary Disease, Chronic Obstructive - blood
/ Pulmonary Disease, Chronic Obstructive - diagnosis
/ Pulmonary Disease, Chronic Obstructive - etiology
/ smoke
/ Smokers
/ Smoking
